🕒 Monday 11 August 2025 Mon, 11 Aug 2025

Astral Resources has reported exceptional high-grade gold assay results within the pit shell at its Kamperman deposit, bolstering the Mandilla Pre-Feasibility Study and highlighting growth potential across its Feysville Gold Project.

Invex Therapeutics reports a significantly reduced net loss for FY25, driven by lower R&D costs after closing its Phase III trial, while advancing promising pre-clinical Alzheimer’s research through a collaboration with Tessara Therapeutics.

ResMed Inc. reported a robust 10% increase in revenue to $5.15 billion for fiscal 2025, driven by strong demand in sleep and breathing health devices and residential care software. The company also expanded its diagnostic capabilities with the acquisition of VirtuOx, positioning itself for further growth in home-based health solutions.

MAC Copper has secured a crucial regulatory green light from the South African Reserve Bank, advancing Harmony Gold’s proposed acquisition. Shareholders are now gearing up to vote on the deal at meetings scheduled for late August.

Metro Performance Glass is set to strengthen its balance sheet and support its turnaround strategy through a $15 million to $24 million equity raise, with Amari Metals Australia poised to become the majority shareholder. This recapitalisation aims to reduce debt and improve operational focus amid challenging market conditions.

Metro Performance Glass proposes a $15–24 million recapitalisation involving a discounted rights offer and a major placement to Amari Metals, who would become the controlling shareholder.